Diabetes Research Today is a free monthly online journal that collates and summarizes the latest research about Diabetes, including details on insulin, type i, type ii, diet, treatment, prevention.

Volume 2 (2005), Issue 2 (February)

1. Prevention of type 2 diabetes: issues and strategies for identifying persons for interventions.
   Diabetes Technol Ther, 6(6): 874-82. [Abstract] [Full-text]
2. Thiazolidinediones: a review of their mechanisms of insulin sensitization, therapeutic potential, clinical efficacy, and tolerability.
   Diabetes Technol Ther, 6(6): 850-63. [Abstract] [Full-text]
3. Correlation between anthropometric parameters and abdominal fat volumes assessed by a magnetic resonance imaging method in patients with diabetes.
   Diabetes Technol Ther, 6(6): 844-9. [Abstract] [Full-text]
4. IRIS II Study: Sensitivity and specificity of intact proinsulin, adiponectin, and the proinsulin/adiponectin ratio as markers for insulin resistance.
   Diabetes Technol Ther, 6(6): 836-43. [Abstract] [Full-text]
5. Impact of MyCareTeam for poorly controlled diabetes mellitus.
   Diabetes Technol Ther, 6(6): 828-35. [Abstract] [Full-text]
6. Median and ulnar nerve conduction measurements in patients with symptoms of diabetic peripheral neuropathy using the NC-stat system.
   Diabetes Technol Ther, 6(6): 816-24. [Abstract] [Full-text]
7. Compliance with inhaled insulin treatment using the AERx iDMS Insulin Diabetes Management System.
   Diabetes Technol Ther, 6(6): 800-7. [Abstract] [Full-text]
8. Clinical performance of a continuous viscometric affinity sensor for glucose.
   Diabetes Technol Ther, 6(6): 790-9. [Abstract] [Full-text]
9. Strategic planning for Medicare coverage and payment of new diabetes technologies.
   Diabetes Technol Ther, 6(6): 776-81. [Abstract] [Full-text]
10. Lack of compensatory increase in islet blood flow and islet mass in GK rats following 60% partial pancreatectomy.
    J Endocrinol, 184(2): 319-27. [Abstract] [Full-text]
11. Experience of social stigma by people with schizophrenia in Hong Kong.
    Br J Psychiatry, 186: 153-7. [Abstract] [Full-text]
12. Diabetes mellitus and breast cancer.
    Lancet Oncol, 6(2): 103-11. [Abstract] [Full-text]
13. Altered redox status in patients with diabetes mellitus type I.
    Pharmacol Res, 51(4): 375-80. [Abstract] [Full-text]
14. Coronary artery disease alters ventricular repolarization dynamics in type 2 diabetes.
    Pacing Clin Electrophysiol, 28: S178-81. [Abstract] [Full-text]
15. Diminished Th1-like response to autoantigens in children with a high risk of developing type 1 diabetes.
    Scand J Immunol, 61(2): 173-9. [Abstract] [Full-text]
16. Influence on spontaneous tissue inflammation by the major histocompatibility complex region in the nonobese diabetic mouse.
    Scand J Immunol, 61(2): 119-27. [Abstract] [Full-text]
17. Glucose tolerance in pregnancy in South India: relationships to neonatal anthropometry.
    Acta Obstet Gynecol Scand, 84(2): 159-65. [Abstract] [Full-text]
18. Impact of a diabetes prevention program on body size, physical activity, and diet among Kanien'keha:ka (Mohawk) children 6 to 11 years old: 8-year results from the Kahnawake Schools Diabetes Prevention Project.
    Pediatrics, 115(2): 333-9. [Abstract] [Full-text]
19. Diagnosis of HNF-1alpha mutations on a PNA zip-code microarray by single base extension.
    Nucleic Acids Res, 33(2): e19. [Abstract] [Full-text]
20. Social and psychological characteristics of Kuwaiti children and adolescents with type 1 diabetes.
    Soc Sci Med, 60(8): 1835-44. [Abstract] [Full-text]
21. Effect of donor treatment with heparinoids on graft function after intraportal transplantation of a marginal islet mass: an experimental study.
    Transplant Proc, 36(10): 3117-20. [Abstract] [Full-text]
22. Impact of kidney transplantation on glycemic control and cardiovascular risk factors in insulin-treated diabetic patients receiving cyclosporine: a longitudinal study.
    Transplant Proc, 36(10): 3012-5. [Abstract] [Full-text]
23. Diabetic fibrous mastopathy: sonographic-pathologic correlation.
    J Clin Ultrasound, 33(1): 34-7. [Abstract] [Full-text]
24. Megalourethra: A report of three cases associated with maternal diabetes and a review of the literature--is sonic hedgehog the common pathway?
    Am J Med Genet A, 132(3): 314-7. [Abstract] [Full-text]
25. Low-density lipoprotein size and subclasses are markers of clinically apparent and non-apparent atherosclerosis in type 2 diabetes.
    Metabolism, 54(2): 227-34. [Abstract] [Full-text]
26. Albuminuria and hypertension are independently associated with circulating antipericyte autoantibodies in type 2 diabetic patients.
    Metabolism, 54(2): 188-93. [Abstract] [Full-text]
27. MUNC-ing around with insulin action.
    J Clin Invest, 115(2): 219-21. [Abstract] [Full-text]
28. Mechanisms through which bradykinin promotes glomerular injury in diabetes.
    Am J Physiol Renal Physiol, 288(3): F483-92. [Abstract] [Full-text]
29. Influence of diabetes and bilateral internal thoracic artery grafts on long-term outcome for multivessel coronary artery bypass grafting.
    Eur J Cardiothorac Surg, 27(2): 281-8. [Abstract] [Full-text]
30. Deletion of Cdkn1b ameliorates hyperglycemia by maintaining compensatory hyperinsulinemia in diabetic mice.
    Nat Med, 11(2): 175-82. [Abstract] [Full-text]
31. Toll-like receptor engagement converts T-cell autoreactivity into overt autoimmune disease.
    Nat Med, 11(2): 138-45. [Abstract] [Full-text]
32. The impact of diabetes mellitus and other chronic medical conditions on health-related Quality of Life: is the whole greater than the sum of its parts?
    Health Qual Life Outcomes, 3(1): 2. [Abstract] [Full-text]
33. Preoperative cardiac evaluation does not improve or predict perioperative or late survival in asymptomatic diabetic patients undergoing elective infrainguinal arterial reconstruction.
    J Vasc Surg, 41(1): 38-45; discussion 45. [Abstract] [Full-text]
34. Maternal and fetal amino acid concentrations in normal pregnancies and in pregnancies with gestational diabetes mellitus.
    Am J Obstet Gynecol, 192(2): 610-7. [Abstract] [Full-text]
35. Dynamic contrast enhanced magnetic resonance imaging and magnetic resonance spectroscopy in diabetic mastopathy.
    Breast, 14(1): 68-70. [Abstract] [Full-text]
36. Comprehensive risk reduction of cardiovascular risk factors in the diabetic patient: an integrated approach.
    Cardiol Clin, 23(2): 193-210. [Abstract] [Full-text]
37. Percutaneous coronary intervention versus coronary artery bypass grafting in diabetic patients.
    Cardiol Clin, 23(2): 185-91. [Abstract] [Full-text]
38. The role of lipid management in diabetes.
    Cardiol Clin, 23(2): 153-64, vi. [Abstract] [Full-text]
39. Diabetes and hypertension, the deadly duet: importance, therapeutic strategy, and selection of drug therapy.
    Cardiol Clin, 23(2): 139-52. [Abstract] [Full-text]
40. Role of insulin secretagogues and insulin sensitizing agents in the prevention of cardiovascular disease in patients who have diabetes.
    Cardiol Clin, 23(2): 119-38. [Abstract] [Full-text]
41. A chlorogenic acid-induced increase in GLP-1 production may mediate the impact of heavy coffee consumption on diabetes risk.
    Med Hypotheses, 64(4): 848-53. [Abstract] [Full-text]
42. Making improvements in the management of patients with type 2 diabetes: a possible role for the control of variation in glycated hemoglobin.
    Med Hypotheses, 64(4): 792-801. [Abstract] [Full-text]
43. Gestational diabetes mellitus in Chinese women.
    Int J Gynaecol Obstet, 88(2): 122-6. [Abstract] [Full-text]
44. The dual PPARalpha/gamma agonist, ragaglitazar, improves insulin sensitivity and metabolic profile equally with pioglitazone in diabetic and dietary obese ZDF rats.
    Br J Pharmacol, 144(3): 308-16. [Abstract] [Full-text]
45. The power of an integrated informatic and molecular approach to type 1 diabetes research.
    Ann N Y Acad Sci, 1037: 216-24. [Abstract] [Full-text]
46. Experimental autoimmune diabetes: a new tool to study mechanisms and consequences of insulin-specific autoimmunity.
    Ann N Y Acad Sci, 1037: 208-15. [Abstract] [Full-text]
47. Identification of key beta cell gene signaling pathways involved in type 1 diabetes.
    Ann N Y Acad Sci, 1037: 203-7. [Abstract] [Full-text]
48. Immunohistochemical demonstration of nitrotyrosine, a biomarker of oxidative stress, in islet cells of the NOD mouse.
    Ann N Y Acad Sci, 1037: 199-202. [Abstract] [Full-text]
49. Molecular pathways altered by insulin b9-23 immunization.
    Ann N Y Acad Sci, 1037: 175-85. [Abstract] [Full-text]
50. Association of the polymorphism for Toll-like receptor 2 with type 1 diabetes susceptibility.
    Ann N Y Acad Sci, 1037: 170-4. [Abstract] [Full-text]
51. Killer cell immunoglobulin-like receptor genes in Latvian patients with type 1 diabetes mellitus and healthy controls.
    Ann N Y Acad Sci, 1037: 161-9. [Abstract] [Full-text]
52. A second-generation genome screen for linkage to type 1 diabetes in a Bedouin Arab family.
    Ann N Y Acad Sci, 1037: 157-60. [Abstract] [Full-text]
53. IDDM17: polymorphisms in the AMACO gene are associated with dominant protection against type 1A diabetes in a Bedouin Arab family.
    Ann N Y Acad Sci, 1037: 145-9. [Abstract] [Full-text]
54. Frequency of MICA in all babies in southeast Sweden (ABIS) positive for high-risk HLA-DQ associated with type 1 diabetes.
    Ann N Y Acad Sci, 1037: 138-44. [Abstract] [Full-text]
55. Prevalence of autoantibodies to carbonic anhydrase II and lactoferrin in patients with type 1 diabetes.
    Ann N Y Acad Sci, 1037: 131-2. [Abstract] [Full-text]
56. No association of INS-VNTR genotype and IAA autoantibodies.
    Ann N Y Acad Sci, 1037: 127-30. [Abstract] [Full-text]
57. Optimal cutoff point of glutamate decarboxylase antibody titers in differentiating two subtypes of adult-onset latent autoimmune diabetes.
    Ann N Y Acad Sci, 1037: 122-6. [Abstract] [Full-text]
58. Prevalence of GAD65 antibodies in lean subjects with type 2 diabetes.
    Ann N Y Acad Sci, 1037: 118-21. [Abstract] [Full-text]
59. Prevalence of diabetes-associated autoantibodies in schoolchildren: the Karlsburg Type 1 Diabetes Risk Study.
    Ann N Y Acad Sci, 1037: 114-7. [Abstract] [Full-text]
60. Mothers' attachment insecurity and diabetes-related autoantibodies in their infants.
    Ann N Y Acad Sci, 1037: 110-3. [Abstract] [Full-text]
61. Closer association of IA-2 humoral autoreactivity with HLA DR3/4 than DQB1*0201/*0302 in Korean T1D patients.
    Ann N Y Acad Sci, 1037: 104-9. [Abstract] [Full-text]
62. Is Type 1 diabetes in the Japanese population the same as among Caucasians?
    Ann N Y Acad Sci, 1037: 96-103. [Abstract] [Full-text]
63. Stromal cell-derived factor-1 chemokine gene variant in patients with type 1 diabetes and autoimmune thyroid disease.
    Ann N Y Acad Sci, 1037: 79-83. [Abstract] [Full-text]
64. Monocytic expression behavior of cytokines in diabetic patients upon inflammatory stimulation.
    Ann N Y Acad Sci, 1037: 74-8. [Abstract] [Full-text]
65. Differential expression of nonislet autoimmunity: comparison of Korean and U.S. patients with type 1 diabetes.
    Ann N Y Acad Sci, 1037: 69-73. [Abstract] [Full-text]
66. Elevated lymphocyte expression of CLIP is associated with type 1 diabetes and may be a useful marker of autoimmune susceptibility.
    Ann N Y Acad Sci, 1037: 65-8. [Abstract] [Full-text]
67. GAD-reactive T cells were mainly detected in autoimmune-related type 1 diabetic patients with HLA DR9.
    Ann N Y Acad Sci, 1037: 33-40. [Abstract] [Full-text]
68. Preproinsulin-specific CD8+ T cells secrete IFNgamma in human type 1 diabetes.
    Ann N Y Acad Sci, 1037: 22-5. [Abstract] [Full-text]
69. CD4+ T cell proliferation in response to GAD and proinsulin in healthy, pre-diabetic, and diabetic donors.
    Ann N Y Acad Sci, 1037: 16-21. [Abstract] [Full-text]
70. Detection of autoreactive T cells in type 1 diabetes using coded autoantigens and an immunoglobulin-free cytokine ELISPOT assay: report from the fourth immunology of diabetes society T cell workshop.
    Ann N Y Acad Sci, 1037: 10-5. [Abstract] [Full-text]
71. Use of anti-CD3 monoclonal antibody to induce immune regulation in type 1 diabetes.
    Ann N Y Acad Sci, 1037: 1-9. [Abstract] [Full-text]
72. Clinical importance of cystic fibrosis-related diabetes.
    J Cyst Fibros, 3(4): 209-22. [Abstract] [Full-text]
73. Tyrosine kinase-mediated activation of NADPH oxidase enhances proliferative capacity of diabetic vascular smooth muscle cells.
    Life Sci, 76(15): 1747-57. [Abstract] [Full-text]
74. Attenuation of hyperglycemia and associated biochemical parameters in STZ-induced diabetic rats by dietary supplementation of potato peel powder.
    Clin Chim Acta, 353(1): 165-75. [Abstract] [Full-text]
75. Antioxidant parameters and lipid peroxidation in salivary glands of streptozotocin-induced diabetic rats.
    Clin Chim Acta, 353(1): 133-9. [Abstract] [Full-text]
76. Effects of diacylglycerol ingestion on postprandial hyperlipidemia in diabetes.
    Clin Chim Acta, 353(1): 87-94. [Abstract] [Full-text]
77. Serum fetuin-A in nondialyzed patients with diabetic nephropathy: relationship with coronary artery calcification.
    Kidney Int, 67(3): 1070-7. [Abstract] [Full-text]
78. ACE and non-ACE pathways in the renal vascular response to RAS interruption in type 1 diabetes mellitus.
    Kidney Int, 67(3): 1033-7. [Abstract] [Full-text]
79. Angiotensin II receptor blocker inhibits p27Kip1 expression in glucose-stimulated podocytes and in diabetic glomeruli.
    Kidney Int, 67(3): 944-52. [Abstract] [Full-text]
80. Purinergic modulation of mesangial extracellular matrix production: role in diabetic and other glomerular diseases.
    Kidney Int, 67(3): 875-85. [Abstract] [Full-text]
81. No evidence of association or interaction between the IL4RA, IL4, and IL13 genes in type 1 diabetes.
    Am J Hum Genet, 76(3): 517-21. [Abstract] [Full-text]
82. Insulin resistance is associated with impaired nitric oxide synthase activity in skeletal muscle of type 2 diabetic subjects.
    J Clin Endocrinol Metab, 90(2): 1100-5. [Abstract] [Full-text]
83. Diabetes induces p66shc gene expression in human peripheral blood mononuclear cells: relationship to oxidative stress.
    J Clin Endocrinol Metab, 90(2): 1130-6. [Abstract] [Full-text]
84. The common -866G/A polymorphism in the promoter region of the UCP-2 gene is associated with reduced risk of type 2 diabetes in Caucasians from Italy.
    J Clin Endocrinol Metab, 90(2): 1176-80. [Abstract] [Full-text]
85. The insulin gene variable number tandem repeat and risk of type 2 diabetes in a population-based sample of families and unrelated men and women.
    J Clin Endocrinol Metab, 90(2): 1137-43. [Abstract] [Full-text]
86. Molecular screening and association analyses of the interleukin 6 receptor gene variants with type 2 diabetes, diabetic nephropathy, and insulin sensitivity.
    J Clin Endocrinol Metab, 90(2): 1123-9. [Abstract] [Full-text]
87. Inhibition of vascular endothelial growth factor (VEGF) does not affect early renal changes in a rat model of lean type 2 diabetes.
    Horm Metab Res, 37(1): 21-5. [Abstract] [Full-text]
88. Under-recognised paradox of neuropathy from rapid glycaemic control.
    Postgrad Med J, 81(952): 103-7. [Abstract] [Full-text]
89. Fine-tuning therapy with basal insulin for optimal glycemic control in type 2 diabetes: a review.
    Curr Med Res Opin, 20(12): 2007-14. [Abstract] [Full-text]
90. Treatment of the patient with diabetes: importance of maintaining target HbA(1c) levels.
    Curr Med Res Opin, 20(12): 1919-27. [Abstract] [Full-text]
91. Use of losartan in diabetic patients in the primary care setting: review of the results in LIFE and RENAAL.
    Curr Med Res Opin, 20(12): 1909-17. [Abstract] [Full-text]
92. Salvage of the neuropathic foot by using bone resection and tendon balancing: a retrospective review of 10 patients.
    J Foot Ankle Surg, 44(1): 37-43. [Abstract] [Full-text]
93. Severe hypoglycaemia, metabolic control and diabetes management in children with type 1 diabetes in the decade after the Diabetes Control and Complications Trial -- a large-scale multicentre study.
    Eur J Pediatr, 164(2): 73-9. [Abstract] [Full-text]
94. Role of lipids in the early developmental stages of experimental immune diabetes induced by multiple low-dose streptozotocin.
    J Appl Physiol, 98(3): 1064-9. [Abstract] [Full-text]
95. Prevailing hyperglycemia is critical in the regulation of glucose metabolism during exercise in poorly controlled alloxan-diabetic dogs.
    J Appl Physiol, 98(3): 930-9. [Abstract] [Full-text]
96. Vascular endothelial growth factor and its soluble receptor, Flt-1, are not correlated to erythropoietin in diabetics with normal or reduced renal function.
    Nephrology (Carlton), 10(1): 84-9. [Abstract] [Full-text]
97. Differential expression of aquaporins in the kidneys of streptozotocin-induced diabetic mice.
    Nephrology (Carlton), 10(1): 63-72. [Abstract] [Full-text]
98. Glycosylated haemoglobin levels and the severity of erectile function in diabetic men.
    BJU Int, 95(4): 615-7. [Abstract] [Full-text]
99. Nonproliferative retinopathy in diabetes type 2. Initial stages and characterization of phenotypes.
    Prog Retin Eye Res, 24(3): 355-77. [Abstract] [Full-text]
100. Impact of diabetes mellitus on myocardial perfusion after primary angioplasty in patients with acute myocardial infarction.
     J Am Coll Cardiol, 45(4): 508-14. [Abstract] [Full-text]
101. Drug-eluting stents for diabetes mellitus: a rush to judgment?
     J Am Coll Cardiol, 45(4): 479-83. [Abstract] [Full-text]
102. Serum calcineurin activity in relation to oxidative stress and glycemic control in type II diabetes mellitus.
     Clin Biochem, 38(3): 218-22. [Abstract] [Full-text]
103. Endothelial inflammation in insulin resistance.
     Lancet, 365(9459): 610-2. [Abstract] [Full-text]
104. Study of the hypoglycaemic activity of Lepidium sativum L. aqueous extract in normal and diabetic rats.
     J Ethnopharmacol, 97(2): 391-5. [Abstract] [Full-text]
105. Antidiabetic activity of alcoholic stem extract of Coscinium fenestratum in streptozotocin-nicotinamide induced type 2 diabetic rats.
     J Ethnopharmacol, 97(2): 369-74. [Abstract] [Full-text]
106. Hypoglycemic effects of Murraya koenigii on normal and alloxan-diabetic rabbits.
     J Ethnopharmacol, 97(2): 247-51. [Abstract] [Full-text]
107. Effect of ethanolic extract of Zingiber officinale on dyslipidaemia in diabetic rats.
     J Ethnopharmacol, 97(2): 227-30. [Abstract] [Full-text]
108. A double blind randomised placebo controlled cross over study of a herbal preparation containing Salacia reticulata in the treatment of type 2 diabetes.
     J Ethnopharmacol, 97(2): 215-8. [Abstract] [Full-text]
109. The collaborative atorvastatin diabetes study: preliminary results.
     Int J Clin Pract, 59(1): 121-3. [Abstract] [Full-text]
110. Self-care in diabetes: model of factors affecting self-care.
     J Clin Nurs, 14(3): 301-14. [Abstract] [Full-text]
111. Glomerular proliferation during early stages of diabetic nephropathy is associated with local increase of sphingosine-1-phosphate levels.
     FEBS Lett, 579(5): 1249-54. [Abstract] [Full-text]
112. Bisulphite sequencing of the transient neonatal diabetes mellitus DMR facilitates a novel diagnostic test but reveals no methylation anomalies in patients of unknown aetiology.
     Hum Genet, 116(4): 255-61. [Abstract] [Full-text]
113. A genome-wide scan for quantitative trait loci linked to obesity phenotypes among West Africans.
     Int J Obes (Lond), 29(3): 255-9. [Abstract] [Full-text]
114. Role of the FOXC2 -512C>T polymorphism in type 2 diabetes: possible association with the dysmetabolic syndrome.
     Int J Obes (Lond), 29(3): 268-74. [Abstract] [Full-text]
115. Pulsatility index of temporal and renal arteries as an early finding of arteriopathy in diabetic patients.
     Ann Vasc Surg, 19(1): 80-3. [Abstract] [Full-text]
116. Single-donor, marginal-dose islet transplantation in patients with type 1 diabetes.
     JAMA, 293(7): 830-5. [Abstract] [Full-text]
117. Contraception in diabetic women: an Italian study.
     Diabetes Res Clin Pract, 67(3): 267-72. [Abstract] [Full-text]
118. Microalbuminuria and risk factors in type 1 and type 2 diabetic patients.
     Diabetes Res Clin Pract, 67(3): 258-66. [Abstract] [Full-text]
119. Prevalence of Type 2 diabetes and central adiposity in La Reunion Island, the REDIA Study.
     Diabetes Res Clin Pract, 67(3): 234-42. [Abstract] [Full-text]
120. Past 10-year status of insulin therapy for preschool-age Japanese children with type 1 diabetes.
     Diabetes Res Clin Pract, 67(3): 227-33. [Abstract] [Full-text]
121. Relationship between the ability to recognize energy intake and expenditure, and blood sugar control in type 2 diabetes mellitus patients.
     Diabetes Res Clin Pract, 67(3): 220-6. [Abstract] [Full-text]
122. The electrophysiological findings of subclinical neuropathy in patients with recently diagnosed type 1 diabetes mellitus.
     Diabetes Res Clin Pract, 67(3): 211-9. [Abstract] [Full-text]
123. alpha-Glucosidase inhibitor reduces the progression of carotid intima-media thickness.
     Diabetes Res Clin Pract, 67(3): 204-10. [Abstract] [Full-text]
124. The effect of improved post-prandial blood glucose control on post-prandial metabolism and markers of vascular risk in people with Type 2 diabetes.
     Diabetes Res Clin Pract, 67(3): 196-203. [Abstract] [Full-text]
125. Potent hypoglycaemic activity of the aqueous extract of Chamaemelum nobile in normal and streptozotocin-induced diabetic rats.
     Diabetes Res Clin Pract, 67(3): 189-95. [Abstract] [Full-text]
126. Effects of the Ca2+ antagonist nimodipine on functional deficits in the peripheral and central nervous system of streptozotocin-diabetic rats.
     Brain Res, 1035(1): 86-93. [Abstract] [Full-text]
127. Effects of hyperglycaemia on ocular development in rabbit: refraction and biometric changes.
     Ophthalmic Physiol Opt, 25(2): 97-104. [Abstract] [Full-text]
128. Curcuminoids and sesquiterpenoids in turmeric (Curcuma longa L.) suppress an increase in blood glucose level in type 2 diabetic KK-Ay mice.
     J Agric Food Chem, 53(4): 959-63. [Abstract] [Full-text]
129. Haematocrit, type 2 diabetes, and endothelium-dependent vasodilatation of resistance vessels.
     Eur Heart J, 26(5): 464-71. [Abstract] [Full-text]
130. Defective glucose-stimulated insulin release in the diabetic Goto-Kakizaki (GK) rat coincides with reduced activity of the islet carbon monoxide signaling pathway.
     Endocrinology, 146(3): 1553-8. [Abstract] [Full-text]
131. Admission blood glucose and short term survival in primary intracerebral haemorrhage: a population based study.
     J Neurol Neurosurg Psychiatry, 76(3): 349-53. [Abstract] [Full-text]
132. Diabetes mellitus and the risk of prostate cancer in Italy.
     Eur Urol, 47(3): 313-7; discussion 317. [Abstract] [Full-text]
133. Cataracts in experimentally diabetic mouse: morphological and apoptotic changes.
     Diabetes Obes Metab, 7(2): 200-4. [Abstract] [Full-text]
134. Effects of metformin on the body composition in subjects with risk factors for type 2 diabetes.
     Diabetes Obes Metab, 7(2): 189-92. [Abstract] [Full-text]
135. Improvement of glucose tolerance in Zucker diabetic fatty rats by long-term treatment with the dipeptidyl peptidase inhibitor P32/98: comparison with and combination with rosiglitazone.
     Diabetes Obes Metab, 7(2): 170-81. [Abstract] [Full-text]
136. An algorithm for the treatment of type 2 diabetes in Latin America.
     Diabetes Obes Metab, 7(2): 148-60. [Abstract] [Full-text]
137. QT dispersion in type 2 diabetic patients with altered diurnal blood pressure rhythm.
     Diabetes Obes Metab, 7(2): 136-43. [Abstract] [Full-text]
138. Genetics of type 2 diabetes mellitus: status and perspectives.
     Diabetes Obes Metab, 7(2): 122-35. [Abstract] [Full-text]
139. Nt-proANP in plasma, a marker of salt sensitivity, is reduced in type 2 diabetes patients.
     J Intern Med, 257(3): 281-8. [Abstract] [Full-text]
140. The Pro387Leu variant of protein tyrosine phosphatase-1B is not associated with diabetes mellitus type 2 in a German population.
     J Intern Med, 257(3): 272-80. [Abstract] [Full-text]
141. Intravitreal triamcinolone for macular oedema: efficacy in relation to aetiology.
     Acta Ophthalmol Scand, 83(1): 67-70. [Abstract] [Full-text]
142. Serous macular detachment in diabetic cystoid macular oedema.
     Acta Ophthalmol Scand, 83(1): 63-6. [Abstract] [Full-text]
143. Vasoactive mediators and retinopathy during type 1 diabetic pregnancy.
     Acta Ophthalmol Scand, 83(1): 57-62. [Abstract] [Full-text]
144. Rapid determination of acetone in human blood by derivatization with pentafluorobenzyl hydroxylamine followed by headspace liquid-phase microextraction and gas chromatography/mass spectrometry.
     Rapid Commun Mass Spectrom, 19(5): 647-53. [Abstract] [Full-text]
145. Usefulness of QT-interval parameters for cardiovascular risk stratification in type 2 diabetic patients with arterial hypertension.
     J Hum Hypertens, 19(3): 241-9. [Abstract] [Full-text]
146. The R6/2 transgenic mouse model of Huntington's disease develops diabetes due to deficient beta-cell mass and exocytosis.
     Hum Mol Genet, 14(5): 565-74. [Abstract] [Full-text]
147. Effects of antioxidant treatment on normal and diabetic rat retinal enzyme activities.
     J Ocul Pharmacol Ther, 21(1): 28-35. [Abstract] [Full-text]
148. The Diabetes Continuity of Care Scale: the development and initial evaluation of a questionnaire that measures continuity of care from the patient perspective.
     Health Soc Care Community, 12(6): 475-87. [Abstract] [Full-text]
149. The annual incidence of diabetic complications in a population of patients with Type 1 and Type 2 diabetes.
     Diabet Med, 22(3): 348-52. [Abstract] [Full-text]
150. Improvement of glycaemic control with rebound following orlistat initiation and cessation associated with minimal weight change.
     Diabet Med, 22(3): 344-5. [Abstract] [Full-text]
151. Hepatitis C virus infection-related Type 1 diabetes mellitus.
     Diabet Med, 22(3): 340-3. [Abstract] [Full-text]
152. Routine diagnosis of Type 2 diabetes mellitus in general practice and hospitals: how do patients differ?
     Diabet Med, 22(3): 336-9. [Abstract] [Full-text]
153. A comparison of urinary albumin excretion rate and microalbuminuria in various glucose tolerance subjects.
     Diabet Med, 22(3): 332-5. [Abstract] [Full-text]
154. Alcohol consumption and other risk factors for self-reported diabetes among middle-aged Japanese: a population-based prospective study in the JPHC study cohort I.
     Diabet Med, 22(3): 323-31. [Abstract] [Full-text]
155. An intensified lifestyle intervention programme may be superior to insulin treatment in poorly controlled Type 2 diabetic patients on oral hypoglycaemic agents: results of a feasibility study.
     Diabet Med, 22(3): 316-22. [Abstract] [Full-text]
156. Caries risk assessment as a predictor of metabolic control in young Type 1 diabetics.
     Diabet Med, 22(3): 312-5. [Abstract] [Full-text]
157. Insulin sensitivity at diagnosis of Type 2 diabetes is not associated with subsequent cardiovascular disease (UKPDS 67).
     Diabet Med, 22(3): 306-11. [Abstract] [Full-text]
158. Reduced plasma total homocysteine concentrations in Type 1 diabetes mellitus is determined by increased renal clearance.
     Diabet Med, 22(3): 301-5. [Abstract] [Full-text]
159. Affective and anxiety disorders in a German sample of diabetic patients: prevalence, comorbidity and risk factors.
     Diabet Med, 22(3): 293-300. [Abstract] [Full-text]
160. How diabetic patients think about and manage their illness in Taiwan.
     Diabet Med, 22(3): 286-92. [Abstract] [Full-text]
161. Plasma leptin concentration in patients with Type 2 diabetes: relationship to cardiovascular disease risk factors and insulin resistance.
     Diabet Med, 22(3): 278-85. [Abstract] [Full-text]
162. Pharmacokinetic profiles of biphasic insulin aspart 30/70 and 70/30 in patients with Type 1 diabetes: a randomized double-blinded crossover study.
     Diabet Med, 22(3): 273-7. [Abstract] [Full-text]
163. Renal damage in patients with Type 2 diabetes: a strong predictor of mortality.
     Diabet Med, 22(3): 258-65. [Abstract] [Full-text]
164. A mobile screening programme for the cardiovascular and microvascular complications of Type 2 diabetes in primary care.
     Diabet Med, 22(3): 256-7. [Abstract] [Full-text]
165. The effect of multi-factorial intervention on plasma von Willebrand factor, soluble E-selectin and tissue factor in diabetes mellitus: implications for atherosclerotic vascular disease.
     Diabet Med, 22(3): 249-55. [Abstract] [Full-text]
166. The J-shape effect of alcohol intake on the risk of developing acute coronary syndromes in diabetic subjects: the CARDIO2000 II Study.
     Diabet Med, 22(3): 243-8. [Abstract] [Full-text]
167. Statin therapy improves brachial artery vasodilator function in patients with Type 1 diabetes and microalbuminuria.
     Diabet Med, 22(3): 239-42. [Abstract] [Full-text]
168. Foot temperature in diabetic polyneuropathy: innocent bystander or unrecognized accomplice?
     Diabet Med, 22(3): 231-8. [Abstract] [Full-text]
169. RSK4 and PAK5 are novel candidate genes in diabetic rat kidney and brain.
     Mol Pharmacol, 67(3): 604-11. [Abstract] [Full-text]
170. Increased protein glycation in diabetes mellitus is associated with decreased aspirin-mediated protein acetylation and reduced sensitivity of blood platelets to aspirin.
     J Mol Med, 83(2): 148-58. [Abstract] [Full-text]
171. Intensive telephone follow-up to a hospital-based disease management model for patients with diabetes mellitus.
     Dis Manag, 8(1): 15-25. [Abstract] [Full-text]
172. Diffuse diabetic macular oedema treated by intravitreal triamcinolone acetonide: a comparative, non-randomised study.
     Br J Ophthalmol, 89(3): 321-6. [Abstract] [Full-text]
173. A randomised, placebo controlled clinical trial of the aldose reductase inhibitor CT-112 as management of corneal epithelial disorders in diabetic patients.
     Br J Ophthalmol, 89(3): 266-8. [Abstract] [Full-text]
174. Cognitive behavioural group training (CBGT) for patients with type 1 diabetes in persistent poor glycaemic control: who do we reach?
     Patient Educ Couns, 56(3): 313-22. [Abstract] [Full-text]
175. Effect of targeted disruption of signal transducer and activator of transcription (Stat)4 and Stat6 genes on the autoimmune diabetes development induced by multiple low doses of streptozotocin.
     Clin Immunol, 114(3): 299-306. [Abstract] [Full-text]
176. Disproportionate increase in prevalence of diabetes among patients with congestive heart failure due to systolic dysfunction.
     Int J Cardiol, 99(1): 125-7. [Abstract] [Full-text]
177. Analysis of eluted peptides from type 1 diabetes-susceptible HLA class II molecules identified novel islet protein, heparin/heparan sulfate-interacting protein.
     Biochem Biophys Res Commun, 329(1): 356-61. [Abstract] [Full-text]
178. Association of the ABCA1 gene polymorphisms with type 2 DM in a Japanese population.
     Biochem Biophys Res Commun, 329(1): 205-10. [Abstract] [Full-text]
179. Protection of inactivated influenza virus vaccine against lethal influenza virus infection in diabetic mice.
     Biochem Biophys Res Commun, 329(1): 87-94. [Abstract] [Full-text]
180. Modulatory effects of Aloe vera leaf gel extract on oxidative stress in rats treated with streptozotocin.
     J Pharm Pharmacol, 57(2): 241-6. [Abstract] [Full-text]
181. Regulatory polymorphisms underlying complex disease traits.
     J Mol Med, 83(2): 97-109. [Abstract] [Full-text]
182. Evaluation of the UCL diabetes self-management programme (UCL-DSMP): a randomized controlled trial.
     J Health Psychol, 10(2): 261-76. [Abstract] [Full-text]
183. Gestational hyperglycemia, zinc, selenium, and antioxidant vitamins.
     Nutrition, 21(2): 186-91. [Abstract] [Full-text]
184. CD4+CD25high regulatory T cells in human autoimmune diabetes.
     J Autoimmun, 24(1): 55-62. [Abstract] [Full-text]
185. Development of autoreactive diabetogenic T cells in the thymus of NOD mice.
     J Autoimmun, 24(1): 11-23. [Abstract] [Full-text]
186. Heart rate variability in young patients with diabetes mellitus and healthy subjects explored by Poincaré and sequence plots.
     Clin Physiol Funct Imaging, 25(2): 119-27. [Abstract] [Full-text]
187. Impaired microvascular function related to poor metabolic control in young patients with diabetes.
     Clin Physiol Funct Imaging, 25(2): 100-5. [Abstract] [Full-text]
188. Structural, metabolic and endocrine analysis of the diabetes (db/db) hypogonadal syndrome: relationship to hypophyseal hypercytolipidemia.
     Cell Tissue Res, 319(3): 501-12. [Abstract] [Full-text]
189. Mechanism of the hypoglycemic effect of stevioside, a glycoside of Stevia rebaudiana.
     Planta Med, 71(2): 108-13. [Abstract] [Full-text]
190. How does depression influence diabetes medication adherence in older patients?
     Am J Geriatr Psychiatry, 13(3): 202-10. [Abstract] [Full-text]
191. Clozapine-induced type-2 diabetes mellitus: possible mechanisms and implications for clinical practice.
     J Psychopharmacol, 19(2): 207-10. [Abstract] [Full-text]
192. Undiagnosed impaired fasting glucose and diabetes mellitus amongst inpatients receiving antipsychotic drugs.
     J Psychopharmacol, 19(2): 182-6. [Abstract] [Full-text]
193. Advances in diabetic management: implications for anesthesia.
     Anesth Analg, 100(3): 666-9. [Abstract] [Full-text]
194. IRS-1 and vascular complications in diabetes mellitus.
     Vitam Horm, 70: 25-67. [Abstract] [Full-text]
195. Role of the intestinal tight junction modulator zonulin in the pathogenesis of type I diabetes in BB diabetic-prone rats.
     Proc Natl Acad Sci U S A, 102(8): 2916-21. [Abstract] [Full-text]
196. Treatment of type 2 diabetes in primary health care: a drug utilization study.
     Ann Pharmacother, 39(3): 441-5. [Abstract] [Full-text]
197. Caring for poorly controlled diabetes mellitus: a randomized pharmacist intervention.
     Ann Pharmacother, 39(3): 433-40. [Abstract] [Full-text]
198. Insulin detemir--a new basal insulin analog.
     Ann Pharmacother, 39(3): 502-7. [Abstract] [Full-text]
199. Temporary angiotensin II blockade at the prediabetic stage attenuates the development of renal injury in type 2 diabetic rats.
     J Am Soc Nephrol, 16(3): 703-11. [Abstract] [Full-text]
200. Comparison of risk factors for diabetes in children of different socioeconomic status.
     J Coll Physicians Surg Pak, 15(2): 74-7. [Abstract] [Full-text]
201. Post-transplant diabetes mellitus: a case-control analysis of the risk factors.
     Transpl Int, 18(3): 309-12. [Abstract] [Full-text]
202. Protective role of tea catechins against oxidation-induced damage of type 2 diabetic erythrocytes.
     Clin Exp Pharmacol Physiol, 32(1): 70-5. [Abstract] [Full-text]
203. Cardiovascular comorbidities among public health clinic patients with diabetes: the Urban Diabetics Study.
     BMC Public Health, 5(1): 15. [Abstract] [Full-text]
204. Fms-like tyrosine kinase 3 ligand administration overcomes a genetically determined dendritic cell deficiency in NOD mice and protects against diabetes development.
     Int Immunol, 17(3): 307-14. [Abstract] [Full-text]
205. Body composition in diabetic subjects with chronic kidney disease: interest of bio-impedance analysis, and anthropometry.
     Ann Nutr Metab, 48(6): 409-13. [Abstract] [Full-text]
206. Neutrophil function in neonates born to gestational diabetic mothers.
     J Perinatol, 25(3): 178-81. [Abstract] [Full-text]
207. The K469E polymorphism of the intercellular adhesion molecule-1 gene is associated with plasma fibrinogen level in type 2 diabetes.
     Metabolism, 54(3): 381-6. [Abstract] [Full-text]
208. Soluble E-selectin, leptin, triglycerides, and insulin resistance in nonobese Japanese type 2 diabetic patients.
     Metabolism, 54(3): 376-80. [Abstract] [Full-text]
209. High serum pentosidine concentrations are associated with increased arterial stiffness and thickness in patients with type 2 diabetes.
     Metabolism, 54(3): 345-50. [Abstract] [Full-text]
210. The effects of rosiglitazone and metformin on the plasma concentrations of resistin in patients with type 2 diabetes mellitus.
     Metabolism, 54(3): 314-20. [Abstract] [Full-text]
211. Red wine consumption improves insulin resistance but not endothelial function in type 2 diabetic patients.
     Metabolism, 54(3): 306-13. [Abstract] [Full-text]
212. Correlation between the adiponectin-leptin ratio and parameters of insulin resistance in patients with type 2 diabetes.
     Metabolism, 54(3): 281-6. [Abstract] [Full-text]
213. Altered response of insulin-like growth factor-binding protein 1 to nutritional deprivation in type 2 diabetes mellitus.
     Metabolism, 54(3): 275-80. [Abstract] [Full-text]
214. Immune modulation for prevention of type 1 diabetes mellitus.
     Trends Biotechnol, 23(3): 128-34. [Abstract] [Full-text]
215. Posterior subtenon triamcinolone acetonide for refractory diabetic macular edema.
     Am J Ophthalmol, 139(2): 290-4. [Abstract] [Full-text]
216. Multidimensional pharmacologic strategies for diabetes.
     Nurs Clin North Am, 40(1): 107-17. [Abstract] [Full-text]
217. Development of conjugated linoleic acid (CLA)-mediated lipoatrophic syndrome in the mouse.
     Biochimie, 87(1): 73-9. [Abstract] [Full-text]
218. Hearing function in Nigerian children with a family history of type 2 diabetes.
     Int J Pediatr Otorhinolaryngol, 69(3): 387-91. [Abstract] [Full-text]
219. Sensory nerve desensitization by resiniferatoxin improves glucose tolerance and increases insulin secretion in Zucker Diabetic Fatty rats and is associated with reduced plasma activity of dipeptidyl peptidase IV.
     Eur J Pharmacol, 509(2): 211-7. [Abstract] [Full-text]
220. Diabetic neuropathies. Classification, clinical features, and pathophysiological basis.
     Neurologist, 11(2): 63-79. [Abstract] [Full-text]
221. Retinoic acid increases tissue and plasma contents of nerve growth factor and prevents neuropathy in diabetic mice.
     Eur J Clin Invest, 35(3): 201-7. [Abstract] [Full-text]
222. Long-term prognosis of patients after kidney transplantation: a comparison of those with or without diabetes mellitus.
     Nephrol Dial Transplant, 20(3): 611-7. [Abstract] [Full-text]
223. Prevalence of LADA and frequency of GAD antibodies in diabetic patients with end-stage renal disease and dialysis treatment in Austria.
     Nephrol Dial Transplant, 20(3): 559-65. [Abstract] [Full-text]
224. C-peptide prevents glomerular hypertrophy and mesangial matrix expansion in diabetic rats.
     Nephrol Dial Transplant, 20(3): 532-8. [Abstract] [Full-text]
225. P-Cadherin is decreased in diabetic glomeruli and in glucose-stimulated podocytes in vivo and in vitro studies.
     Nephrol Dial Transplant, 20(3): 524-31. [Abstract] [Full-text]

© 2004-2008 Diabetes Research Today. All Rights Reserved.